System: You are an expert Data Annotator. You will be given a text from a company annual…
- User
System: You are an expert Data Annotator. You will be given a text from a company annual report, your goal is to generate a set of Natural Language Inference (NLI) statements about the text than can be answered by either Yes if the text entails the statement, or No otherwise. Do not include any numerical reasoning or numbers in the statements.
Step 1: Read the paragraph carefully. Step 2: For each relevant task you identify, generate two short statements that are shorter than 10 words Step 3: Output the results in the following format:
Question: label: Question: label: ...
User: In the United States and elsewhere, sales of prescription pharmaceuticals depend in large part on the availability of coverage and adequate reimbursement to the consumer from third-party payers, such as government health administration authorities and private insurance plans. Third-party payers are increasingly challenging the prices charged for medical products and services. The market for our approved products depends significantly on access to third-party payers’ formularies, which are the lists of medications and devices for which third-party payers provide coverage and reimbursement. The industry competition to be included in such formularies often leads to downward pricing pressures on pharmaceutical and device companies. Also, third-party payers may refuse to include a particular branded product in their formularies or otherwise restrict patient access to a branded product when a less costly generic equivalent or other alternative is available. Even if favorable coverage and reimbursement status is attained for our products, less favorable coverage policies and reimbursement rates may be implemented in the future. In addition, because each third-party payer individually approves coverage and reimbursement levels, obtaining coverage and adequate reimbursement is a time-consuming and costly process. We may be required to provide scientific and clinical support for the use of any product to each third-party payer separately with no assurance that approval would be obtained. This process could delay the market acceptance of any product and could have a negative effect on our future revenues and operating results. Even if we succeed in bringing more products to market, we cannot be certain that any such products would be considered cost-effective or that coverage and adequate reimbursement to the consumer would be available. Patients will be unlikely to use our products unless coverage is provided and reimbursement is adequate to cover a significant portion of the cost of our products._ Assistant:
- Assistant
Question: Third-party payers affect pharmaceutical sales. label: Yes
Question: Government health authorities influence reimbursement. label: Yes
Question: Formularies list medications and devices. label: Yes
Question: Third-party payers never challenge medical prices. label: No
Question: Downward pricing pressures affect pharmaceutical companies. label: Yes
Question: Branded products are always included in formularies. label: No
Question: Obtaining reimbursement is a quick process. label: No
Question: Scientific support is required for each payer. label: Yes
Question: Market acceptance always assures future revenue. label: No
Question: Patients rely on adequate reimbursement. label: Yes